Sitrin Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-31,685
Closed -$5.21M 40
2019
Q1
$5.21M Buy
31,685
+272
+0.9% +$48.1K 2.8% 22
2018
Q4
$5.91M Buy
31,413
+350
+1% +$64.6K 3.61% 12
2018
Q3
$5.29M Buy
31,063
+642
+2% +$108K 2.84% 21
2018
Q2
$4.99M Buy
30,421
+1,838
+6% +$300K 2.83% 22
2018
Q1
$4.62M Sell
28,583
-13,208
-32% -$2.1M 2.98% 20
2017
Q4
$6.1M Sell
41,791
-608
-1% -$86.6K 3.86% 7
2017
Q3
$5.75M Sell
42,399
-503
-1% -$63.5K 3.7% 10
2017
Q2
$5.37M Buy
+42,902
New +$5.13M 3.64% 11

Other funds holding CME

Sitrin Capital Management's CME Position: Q2 2019 in Review

Sitrin Capital Management sold out of CME Group (CME) in Q2 2019, closing a stake of 31,685 shares — an estimated $5.21M sold.

Sitrin Capital Management first reported a position in CME in Q2 2017 and held it in 8 quarters. The position peaked at $6.1M in Q4 2017. 978 funds tracked by Wall St. Rank hold CME as of Q2 2019.

  • Sitrin Capital Management reported no remaining CME Group position as of Q2 2019 after selling out during the quarter.
  • Sitrin Capital Management sold 31,685 CME Group shares in Q2 2019, an estimated $5.21M.
  • Sitrin Capital Management first reported a position in CME Group in Q2 2017 and held it in 8 quarters.
  • Sitrin Capital Management's CME Group position peaked at $6.1M in Q4 2017.
  • 978 funds tracked by Wall St. Rank held CME Group as of Q2 2019.

Based on Sitrin Capital Management's 13F filing for Q2 2019, filed 17 Jul 2019.